Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion type Assertion NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_head.
- NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_provenance.
- NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion evidence source_evidence_literature NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_provenance.
- NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion SIO_000772 16842166 NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_provenance.
- NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion wasDerivedFrom befree-20150227 NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_provenance.
- NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion wasGeneratedBy ECO_0000203 NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_provenance.